Effects of treatment with oral anticoagulant associated with antibiotic therapy in Covid-19

Not Applicable

Recruiting

• Conditions: Covid-19; B04.820.578.500.540.150

• Registration Number: RBR-7nzwkpg
• Lead Sponsor: niversidade do Sul de Santa Catarina

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-01-06
• Last Update Posted: 29 May 2023
• Study Completion: 2024-07-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients over 18 years of age; clinical suspicion of Covid-19; oxygen saturation between 93% and 97%; at least one more symptom according to the Ministry of Health criteria including tiredness or shortness of breath; fever and chills reported; cough and loss of smell or taste; positive result for the D-dimer test

Exclusion Criteria

Patients with active infectious diseases; immunosuppressive diseases or active cancer; pregnant or lactating women; known renal failure; current use of anticoagulants; contraindication to the use of Edoxaban or Moxifloxacin

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
frequency of individuals who required hospitalization after starting treatment (in %)

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes are not expected<br>